PMGC Holdings (ELAB) Acquisitions (2025 - 2026)

PMGC Holdings' (ELAB) quarterly Acquisitions came in at $3.8 million in Q2 2026, up 89.43% quarter-over-quarter from $2.0 million in Q1 2026.

Analysis

PMGC Holdings (ELAB) Acquisitions (2025 - 2026) Analysis & Trends

PMGC Holdings has disclosed Acquisitions across 2 years of filings, most recently posting $3.8 million for Q2 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Amgen	207.09 Bn	193.10 Bn	7.24 Bn	-
2	Gilead Sciences	179.68 Bn	176.50 Bn	6.22 Bn	11.21 Bn
3	Vertex Pharmaceuticals	131.39 Bn	123.54 Bn	2.84 Bn	-
4	Regeneron Pharmaceuticals	81.79 Bn	73.79 Bn	3.93 Bn	-
5	Argenx Se	61.15 Bn	55.97 Bn	1.37 Bn	-
6	Moderna	53.35 Bn	48.21 Bn	52.00 Mn	-
7	Alnylam Pharmaceuticals	33.40 Bn	30.10 Bn	992.69 Mn	-
8	Biogen	31.66 Bn	30.38 Bn	1.96 Bn	-
9	Roivant Sciences	29.14 Bn	29.14 Bn	1.16 Mn	-
10	PMGC Holdings	2.25 Mn	-16.55 Mn	385,691.00	3.83 Mn

Historic Data

Download Data